Endocyte, Inc. (ECYT) Tops Q4 Loss Views by 4c
Tweet Send to a FriendGet Alerts ECYT Hot Sheet
Trade ECYT Now!
Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
- Dollar Tree, Inc. (DLTR) Tops Q1 EPS by 2c; Issues Muted Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
